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NOLL, B., ET AL.: Atrial Natriuretic Peptide Levels Reflect Hemodynamic Changes Under Pacemaker
Stimulation. Pacemaker stimulation influences plasma levels of atrial natriuretic peptide (ANP). This
study evaluated in individuals withouf impaired myocardial /unction whether a consecutive increase of
pacing rales results in reduced alferation of plasma ANP levels (Tiirroring a pulalive decrease of atrial
contribution to cardiac output. In nine resling patients with DDD pacemakers, absolute and relative ANP
plasma levels were determined under DDD [175 msec AV delay) and WI pacing at a pacing rate of 72, 82,
92, and 113 beats/min. When pacing rates ivere conseculively increased, higher plasma ANP concentra-
tions were measured. However, the differences in relalive ANP levels between DDD and WI pacing
decreased. At 113 beats/min, both relative and absolute ANP levels were nearly identical. There/ore, it
seems likely that the atrial contribution (o cardiac oufpuf at high pacing rates is less important than
at lower frequencies, at least when the overall myocardial /unction is not impaired. (PACE, Vol. 13,
August 1990}
atrial natriurefic peptide, artificial pacemaker stimulation, hemodynamics
Introduction
The atrial natriuretic peptide (ANP) is inti-
mately involved in the regulation of renal and
cardiovascular homeostasis.'^ This hormone,
which is synthesized and stored predominantly in
atrial myoendocrine cells, is capable of exerting
potent, selective, and transient effects on fluid
and electrolyte balance as well as on blood pres-
sure.'^ Increases of ANP plasma levels can be
elicited by atrial stretch caused by volume ex-
pansion, elevation of atrial pressure, and atrial
tachycardia.' •̂''
Pacemaker stimulation influences peripheral
levels of atrial natriuretic peptide.^^ Evidently,
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hemodynamically beneficial pacing modes, such
as AAl or DDD mode, lead to lower ANP plasma
levels compared to VVI mode."̂
The aim of the present study was to investi-
gate in patients without impaired myocardial
function whether dual chamber pacing at higher
rates leads to less pronounced regulation in ANP
plasma levels compared to the VVI mode.^" This
is of special interest, since accumulating evidence
demonstrates that ANP plasma concentrations
obviously mirror the actual hemodynamic conse-
quences of different pacing modes at various pac-
ing rates.
Methods
Nine patients with DDD pacemakers {six with
Intermedics Cosmos [Intermedics. Inc., Freeport,
TX. USA], three with Biotronic Diplos 04/05
[Biotronic, Lake Oswego. OR, USA]) were exam-
ined between 8 and 11 a.m. Their mean age was
73 years. None of them showed clinical evidence
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of valvular heart disease or congestive heart fail-
ure. The respective indications for pacemaker
therapy had been documented in three patients as
second-or third-degree AV block and in six pa-
tients as AV block in addition to sinuatrial block
("binodal disease").
Each pacemaker was programmed to DDD
mode (175 msec AV delay) and VVI mode. Fur-
thermore, different pacing rates (72, 82, 92. 113
beats/min) were chosen. At DDD mode, stimula-
tion of both atrium and ventricle was performed
exclusively by the pacemakers at all pacing rates.
The patients were studied under strict resting
conditions to exclude overlapping effects unre-
lated to those induced by the different pacing
modes.
Blood was drawn from an antecubital vein 10
minutes after changing of pacing mode or rate.
The time setting was chosen since ANP was
shown to have a half-life of 3 minutes in blood.'
Plasma ANP was measured as previously de-
scribed.'" In brief, blood samples were collected
on ice into EDTA tubes containing 500 kU/mL of
the protease inhibitor aprotinin (Trasylol, Bayer
AG, Leverkusen, FRG). After centrifugation at
2,000 g at 4°C for 30 minutes. ANP was extracted
using Cl8-Sep-pak cartridges (Waters Associates.
Milford, MA, USA). Eiuates were stored at -70°C
until assay. ANP was measured using a specific
radioimmunoassay method [Amersham, human
aANP [I 125] radioimmunoassay system, code
RPA.512).
Results are given as absolute ANP plasma
levels during the respective pacing modes or
rates. Relative changes in ANP concentration
were calculated in comparison to lowest levels at
each pacing rate which were assumed to be = 1,
Statistical analysis was performed using one-
way analysis of variance. Differences at the 95%
level were considered significant. All values are
means ± standard deviation (SD).
Results
Table I summarizes the results of ANP deter-
minations in nine patients during DDD and VVI
pacing at 72, 82, 92. and 113 beats/min.
The means of the hormone levels at the re-
spective pacing modes and rates are shown in Fig-
ure 1. At 72. 82, and 92 beats/min, ANP plasma
levels were elevated during VVI pacing compared
to DDD pacing, whereas the hormone levels were
nearly identical at 113 beats/min pacing rate. In-
creasing stimulation frequency led to higher
plasma concentrations of atrial natriuretic pep-
tide.
The relative changes of ANP levels during
the two different pacing modes at the respective
pacing rates are shown in figure 2. During VVI
pacing the relative ANP plasma levels at 72. 82,
and 92 beats/min pacing rate were elevated in
comparison to those under dual chamber pacing.
These differences were statistically significant (P
< 0.05). Whereas the relative ANP plasma con-
Table I.
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Figure 1. Mean absolute ANP plasma leveis during DDD and W I pacing at 72, 82, 92. and 113
beats/min (given are means ± SD).
centrations were twofold higher at 72 and 82
beats/min in W I compared to DDD pacing, the
differences between the two pacemaker stimula-
tion modes at 92 beats/min were less pronounced
and differed only by a factor of 1.3. Finally, the
relative hormone concentrations under DDD and
VVl pacing at 113 beats/min were nearly identi-
cal. These data reveal decreasing differences in
plasma levels of atrial natriuretic peptide be-
tween DDD and W I pacemaker stimulation at
increasing pacing rates.
Discussion
Myoendocrine cardiocytes of mammalian
cardiac atria synthesize and store the ANP. a hor-
mone with a variety of potent effects such as in-
crease of sodium and water excretion, decrease of
systemic or pulmonary vascular resistance, and
suppression of plasma renin, aldosterone, and va-
Recent reports demonstrated that pacemaker
stimulation influences ANP release depending on
pacing mode and pacing rate.""^" The main stim-
ulus for ANP release in cardiac pacing seems to be
an increase of atrial transmural pressure and
stretch. Ellenbogen and co-workers showed in-
creases in ANP levels during sustained ventricu-
lar tachycardia^" as well as in atrial pacing at
higher rates.^^ Haufe et al. found that right ven-
tricular pacing led to a pacing rate dependent in-
crease of ANP plasma levels up to 300%. whereas
significantly higher hormone levels under AAI
pacing occurred only at pacing rates higher than
140 beats/min.^ We previously demonstrated that
variations of AV delay also alter peripheral ANP
plasma levels.'' However, an independent effect of
atrial pacing frequency on plasma concentrations
of atrial natriuretic peptide in humans could not
be identified,
Studies using animal models of cardiac tam-
ponade, designed to prevent atria! stretch during
increases in atrial pressure, implied that the in-
crease in atrial transmural pressure with asso-
ciated atrial stretch acts as the principal mediator
controlling the acute release of ANP.̂
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Figure 2. Mean relative ANP piasma levels during DDD and W I pacing a( 72. 82, 92, and 113
beals/min (given are means ± SD].
At body rest, the share of atrial contraction is
reported to be approximately 10%-20%.^^"-^' At
increasing heart rates, atrial contribution to car-
diac output seems to depend on ventricular func-
tion.̂ ^^^ In patients without impaired myocardial
function the atrial contribution to cardiac output
seems to decrease at higher pacing rates. Samet
and co-workers described that atrioventricular
synchrony led to less pronounced increases in
cardiac index at higher pacing rates compared to
asynchronous pacing at rest/
Karlof demonstrated similar effects of AV se-
quential versus single chamber pacing in patients
with complete heart block at rest and during ex-
ercise.^
Obviously, the atrial contribution seems to
decrease at higher pacing rates in normal sub-
jects. This might explain observations of only low
differences in cardiac output during physical
work in patients under DDD stimulation, com-
pared to W I rate responsive pacing.^'
Enhanced cardiac output due to exercise or
acute increment of pacing rate augments venous
return resulting in elevation of atrial filling and
mean pulmonary capillary wedge pressure
(PCW].̂ '*'̂ ^ Augmented PCW influences atrial
contribution to cardiac output, Greenberg and
co-workers found that atrial contribution tends to
become less effective in elevating stroke volume
when PCW increases.^'' As atrial contribution
seems to decrease at higher pacing rates in pa-
tients with normal cardiac function, left ventricu-
lar preload or PCW becomes more important in
the determination of cardiac output. PCW corre-
lates with mean left atrial pressure.^^^^ As plasma
levels of ANP correlate closely to atrial pressure
and tension,'''"'^ it can be expected that differ-
ences in ANP plasma levels between DDD and
VVl pacing decline as pacing rate increases in pa-
tients without impaired myocardial function.
These theoretical considerations are sup-
ported by our present study. While the relative
ANP plasma concentrations were twofold higher
at 72 and 82 beats/min in W I compared to DDD
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pacing, the differences between the two pace-
maker stimulation modes at 92 beats/min were
less pronounced and only differed by a factor of
1.3. At 113 beats/min both relative and absolute
hormone levels were nearly identical, which
might represent a negligible atrial contribution to
cardiac output at this pacing rate. Furthermore,
this might explain, why a minimum in ANP
plasma levels at a certain AV delay under DDD
mode at 113 beats/min was not found, whereas
such a minimum was detectable at a lower pacing
rate as we described earlier.''
To fully corroborate our findings, it would be
necessary to evaluate ventricular volumes during
atrial pacing in order to precisely document the
differences in atrial contribution to cardiac out-
put.'^' However, this was not possible in the out-
patients examined in our study. Our data demon-
strate that measurements of plasma ANP is a use-
ful method which should supplement invasive
diagnostic approaches in detecting hemodynamic
changes under pacemaker stimulation.
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